Cystagon is one of them. They get access to the drug, but then they have to reapply every few months for their whole life. It's a lifelong condition. It just seems that's a bit of bureaucracy.
The other thing I've heard is that there are drugs that have been on the list in the special access program for 27 years. It seems that at some point, if we're comfortable with the drug, it should somehow make its way onto the provincial formularies.
Will the special access program improvements you're talking about address those three scenarios?